» Articles » PMID: 32495637

Polysaccharide Enzymatic Hydrolysate Suppresses the Growth of Human Colon Cancer Cells Via Inducing Apoptosis

Overview
Journal Cell Transplant
Date 2020 Jun 5
PMID 32495637
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

is a popular traditional Chinese medicine used in China to improve health. Previous researches have revealed that the polysaccharide from could exert diversity activities, including immunomodulation, antioxidant, and antitumor effects. However, the effect of enzymatically hydrolyzed polysaccharide (EGLP) in colorectal cancer (CRC) progression remains unknown. The present research aimed to investigate the antitumor mechanism of EGLP in human colon cancer cells. For this purpose, the cytotoxic effects of EGLP were measured by the (3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di-phenytetrazoliumromide (MTT) method. The apoptosis was evoked upon EGLP treatment, which was assayed using flow cytometry. The results indicated that EGLP may induce apoptosis in human colon cancer cell (HCT-116) cells via the upregulation of BCL-2 associated X protein (Bax), phospho-extracellular regulated protein kinases (P-ERK), and cleaved caspase-3 expression and downregulation of B-cell lymphoma-2 (Bcl-2), phospho-serine/threonine kinase 1 (p-Akt1), and cyclo-oxygen-ase (COX-2) expression. The obtained findings indicated EGLP as a new therapeutic agent in fighting CRC.

Citing Articles

Chinese Medicine in Colorectal Cancer Treatment: From Potential Targets and Mechanisms to Clinical Application.

Guo K, Wang Z, Su X Chin J Integr Med. 2024; .

PMID: 39331211 DOI: 10.1007/s11655-024-4115-8.


The Efficacy of Ganoderma lucidum Extracts on Treating Endometrial Cancer: A Network Pharmacology Approach.

Shi M Reprod Sci. 2024; 31(7):1881-1894.

PMID: 38448739 PMC: 11217070. DOI: 10.1007/s43032-024-01500-3.


Ganoderma lucidum methanolic extract as a potent phytoconstituent: characterization, in-vitro antimicrobial and cytotoxic activity.

Mousavi S, Hashemi S, Gholami A, Omidifar N, Chiang W, Neralla V Sci Rep. 2023; 13(1):17326.

PMID: 37833299 PMC: 10576041. DOI: 10.1038/s41598-023-44135-1.


A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer.

Ye T, Ge Y, Jiang X, Song H, Peng C, Liu B Chin Med. 2023; 18(1):107.

PMID: 37641070 PMC: 10463474. DOI: 10.1186/s13020-023-00811-y.


Research Progress on the Anticancer Activities and Mechanisms of Polysaccharides From .

Wang M, Yu F Front Pharmacol. 2022; 13:891171.

PMID: 35865946 PMC: 9294232. DOI: 10.3389/fphar.2022.891171.


References
1.
Kong M, Yao Y, Zhang H . Antitumor activity of enzymatically hydrolyzed polysaccharide on U14 cervical carcinoma-bearing mice. Int J Immunopathol Pharmacol. 2019; 33:2058738419869489. PMC: 6716173. DOI: 10.1177/2058738419869489. View

2.
Siegel R, DeSantis C, Jemal A . Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64(2):104-17. DOI: 10.3322/caac.21220. View

3.
Yang G, Yang L, Zhuang Y, Qian X, Shen Y . Ganoderma lucidum polysaccharide exerts anti-tumor activity via MAPK pathways in HL-60 acute leukemia cells. J Recept Signal Transduct Res. 2014; 36(1):6-13. DOI: 10.3109/10799893.2014.970275. View

4.
Song G, Lu Y, Yu Z, Xu L, Liu J, Chen K . The inhibitory effect of polysaccharide from Rhizopus nigricans on colitis-associated colorectal cancer. Biomed Pharmacother. 2019; 112:108593. DOI: 10.1016/j.biopha.2019.01.054. View

5.
Yousef B, Hassan H, Zhang L, Jiang Z . Pristimerin exhibits in vitro and in vivo anticancer activities through inhibition of nuclear factor-кB signaling pathway in colorectal cancer cells. Phytomedicine. 2018; 40:140-147. DOI: 10.1016/j.phymed.2018.01.008. View